Antioxidant capacity in Fasciola hepatica patients before and after treatment with triclabendazole alone or in combination with ascorbic acid (vitamin C) and tocofersolan (vitamin E)

Arzneimittel-Forschung/Drug Research

Volumn 53, Issue 3, 2003, Pages 214-220

  Abdel Rehim, Wafaa M ^a   Sharaf, Iman A ^a   Hishmat, Mohamed ^a   El Toukhy, Mervat A ^a   Abo Rawash, Nayer ^a   Fouad, Howayda N ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

CAS 68786 66 3; Fascioliasis, oxidative stress; Oxidative stress; Triclabendazole, blood antioxidant capacity, clinical studies, combination with vitamins C and E

Indexed keywords

ASCORBIC ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; SUPEROXIDE DISMUTASE; TOCOFERSOLAN; TRICLABENDAZOLE;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTHELMINTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FASCIOLA HEPATICA; FASCIOLIASIS; FOLLOW UP; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PATIENT SELECTION; VITAMIN SUPPLEMENTATION;

EID: 0037235130     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297097     Document Type: Article

References (42)

1. Tavares, C., Freitas, P., Alfonso, C., Hepatic fascioliasis. Acta. Med. Port. 10, 213 (1997)
2. Abo El-Hoda, M., El-Sayed, A., El-Sedfy, A., Effect of chronic fascioliasis on gall bladder and its management. J. Med. Res. Inst., Univ. Alexandria Egypt 2, 174 (2000)
3. Lopez, R., Dominguez, A., Garron, C., Successful treatment of human fascioliasis with triclabendazole. Eur. J. Clin. Microbiol. Infect. Dis. 18, 525 (1999)
4. Chitsulo, L., Savioli, L., Triclabendazole and Fascioliasis a new drug to combat an age-old disease. Fact. Sheet. 191, 1 (1998)
5. Hishmat, M., Abou El-Hoda, M., El-Shazly, M., Triclabendazole in treatment of human fascioliasis. Bull. High Instit. Pub. Health 27, 211 (1996)
6. Farag, H., El-Koby, T., Salem, A. et al., Triclabendazole in the treatment of established human fascioliasis. Eastern Medit. Health J. 4, 244 (1998).
7. Jain, S., The accumulation of MDA, a product of fatty acid peroxidation, which can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. J. Biol. Chem. 259, 3391 (1984)
8. Forman, H., Fisher, A., Antioxidant defenses. In: D. Gilbert (ed.), Oxygen and living processes. An interdisciplinary approach, p. 235, Springer Verlag, New York (1982)
9. El-Sheikh, H., Ali, B., Homeida, A., The effect of fascioliasis on the activities of some drug-metabolizing enzymes in desert sheep liver. Br. Vet. J. 148, 249 (1992)
10. Galtier, P, Combon, G., Fernanez, Y., Fasciola: Liver microsomal membrane function in host rat. Exp. Parasit. 78, 175 (1994)
11. Martin, L., Bearer, P., Evaluation of Kato thick smear technique for quantitative diagnosis of helminthes infection. Am. J. Trop. Med. Hyg. 17, 382 (1968)
12. Reitman, S., Frankel, S., Colorimetric method for the determination of serum transaminase activity. Am. J. Clin. Path. 28, 56 (1975)
13. Bowers, G. N., McComb, R. B., Measurement of total alkaline phosphatase activity in human serum. Clin. Chem. 21, 1988 (1975)
14. Stock, K., Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin. Chem. Acta 90, 37 (1978)
15. Stocks, J., Offerman, M. C., Dormandy, T., The susceptibility to auto-oxidation of human red cell lipids in health and disease. Br. J. Haematol. 23, 713 (1972)
16. Beulter, E., Duron, O., Kellely, B., Improved methods for the determination of blood glutathione. J. Lab. Clin. Med. 61, 882 (1963)
17. Paticia, A., Pleban, A., Beachum, J., Determination of selenium concentration and glutathione peroxidase activity in plasma and erythrocytes, a modified method of Paglia and Valentine. Clin. Chem. 28, 311 (1982)
18. Winterbourn, C., Hawkins, R., Brian, K., The estimation of red cell superoxide dismutase activity. J. Lab. Clin. Med. 85, 337 (1975)
19. Armitage, A. (ed.), Statistical methods in medical research, pp. 99-146, Blackwell Scientific Publ., Oxford-Edinburgh (1990)
20. nd ed., McGraw-Hill, New York-Toronto etc. (1957)
21. Archinandritis, A., Theodoropulos, G., Bartsokas, S. et al., Liver fascioliasis, amysterious disease. Report of a case. Acta Hepato-gastroenterol. 32, 40 (1976)
22. Khorsandi, H., Obstructive jaundice due to Fasciola hepatica: Report of two cases. Bull. Soc. Pathol. Exot. Fil. 70, 626 (1977)
23. Hammouda, N., El-Mansory, S., El-Azzoni, M. et al., Therapeutic effect of triclabendazole in patients with fascioliasis in Egypt. J. Egyp. Soc. Parasitol. 25, 137 (1995)
24. Alaam, A., El-Sayad, M., Mona, S. et al., Effect of triclabendazole treatment on lipid peroxides and erythrocyte glutathione reductase in acute and chronic human fascioliasis. J. Med. Res. Inst. 19, 42 (1998)
25. Abdel-Mawla, A., El-Sayed, M., Hishmat, M., Comparative studies on the effect of bithionol, praziquantel and triclabendazole on rabbit's fascioliasis: II. Histopathological and histochemical studies of the liver. J. Med. Res. Inst. 19, 105 (1998)
26. Facino, R., Carini, M., Genchi, C. et al., Participation of lipid peroxidation in the loss of hepatic drug-metabolizing activities in experimental fascioliasis in rat. Pharmacol. Res. 21, 549 (1989)
27. Freeman, B., Crapo, J., Biology of disease: Free radicals and tissue injury. Laboratory Investigation 74, 412 (1982)
28. Solin, M., Ahola, H., Haltia, A. et al., Lipid peroxidation in human proteinuric disease. Kidney Int. 59, 481 (2001)
29. Belinsky, S., Kauffman, F., Thurman, R., Interactions between glycolysis and mixed function oxidase studies with 7-ethoxy coumarin in perfused livers from β-naphthoflavone treated rats. Mol. Pharmacol. 35, 512 (1989)
30. Balei, S., Human fascioliasis: Gall bladder invasion by the flukes in 5 years old boy. Clin. Pediat. 14, 1068 (1975)
31. Etsuo, N., Noriko, N., Hideyasu, T. et al., Interaction among vitamin C, vitamin E and β-carotene. Am. J. Clin. Nutr. 62, 1322 (1995)
32. Abdel-Rahman, S., Abou-Basha, L., El-Sarkawy, A. et al., Glutathione and related enzymes in fascioliasis before and after treatment with Bithinol. Bull. High Inst. Pub. Health 19, 651 (1989)
33. Greighton, J., Pathways and energetics of protein disulfide formation. In: A. Laseson, S. Orrenius, A. Holwes et al. (eds). Function of glutathione, p. 205 Raven Press, New York (1983)
34. Beutler, E., Active transport of glutathione disulphide from erythrocytes. In: A. Aarsson, S. Orrenius, A. Holmgren et al. (eds.), Functions of glutathione, pp. 65-74, Raven. Press, New York (1983)
35. McCay, P., Lai, E., Powells, R. et al., Vitamin E: Interactions with free radicals and ascorbate. Fed. Proc. 45, 481 (1986)
36. Facino, R. M., Carini, M., Gerchi, C. et al., Antihepatotoxic properties of uridine-diphosphoglucose in liver fluke infection. Arzneim-Forsch/Drug Res. 40 (I), 490 (1990)
37. Lii, C., Ko, Y., Chiany, M. et al., Effect of dietary vitamin E on antioxidant status and antioxidant enzyme activities in Sprague- Dawley rats. Nutr. Cancer 32, 95 (1998)
38. Dumontet, C., Drai, J., Thieblemont C. et al., The superoxide dismutase content in erythrocytes predicts short-term toxicity of high dose cyclophosphamide. Br. J. Haematol. 112, 405 (2001)
39. Blum, J., Fridovich, I., Inactivation of glutathione peroxidase by superoxide radical. Arch. Biochim. Biophys. 240, 500 (1985)
40. Laburte, C., Mott, K., Mull, R. et al., Ticlabendazole for fascioliasis efficacy and tolerability of a single treatment. J. Med. Res. Inst. (1997); International Conference on Infectious Diseases and Public Health-Abst. 41
41. Stahl, W., Sies, H., Antioxidants defense: vitamin E and C and carotenoids. Diabetes 46, S 14 (1997)
42. Aydemir, T., Ozturk, R., Bozkaya, L., Effects of antioxidant vitamins A, C, E and trace elements Cu, Se on Cu Zn SOD, GSH-PX, CAT and LPO levels in chicken erythrocyte. Cell. Biochem. Funct. 18, 109 (2000)